![](/img/cover-not-exists.png)
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer
Musende, Alain Gulenga, Eberding, Andy, Wood, Catherine A., Adomat, Hans, Fazli, Ladan, Hurtado-Coll, Antonio, Jia, William, Bally, Marcel B., Tomlinson Guns, Emma S.Volume:
23
Language:
english
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0b013e32835006f5
Date:
June, 2012
File:
PDF, 604 KB
english, 2012